医学
糖尿病性视网膜病变
眼科
黄斑水肿
糖尿病
糖尿病性黄斑水肿
新生血管
并发症
视力
视网膜病变
外科
内科学
血管生成
内分泌学
作者
Atul Arora,Arvind Kumar Morya,Parul Chawla Gupta,Nitin Kumar,Prateek Nishant,Vishali Gupta
出处
期刊:World journal of experimental medicine
[Baishideng Publishing Group Co (World Journal of Experimental Medicine)]
日期:2024-10-29
卷期号:14 (4)
标识
DOI:10.5493/wjem.v14.i4.99235
摘要
Diabetic retinopathy (DR) is a serious microvascular complication of diabetes mellitus and may result in irreversible visual loss. Laser treatment has been the gold standard treatment for diabetic macular edema and proliferative diabetic retinopathy for many years. Of late, intravitreal therapy has emerged as a cornerstone in the management of DR. Among the diverse pharmacotherapeutic options, anti-vascular endothelial growth factor agents have demonstrated remarkable efficacy by attenuating neovascularization and reducing macular edema, thus preserving visual acuity in DR patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI